Lincoln Pharma Schedules 32nd AGM, Proposes 18% Final Dividend

Lincoln Pharmaceuticals Ltd has announced that its 32nd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 11:00 a.m. IST, conducted via Video Conferencing/Other Audio-Visual Means. The company also informed about the book closure period from Saturday, September 12, 2026, to Wednesday, September 30, 2026. This period is for determining shareholder entitlement for a proposed final dividend of 18%, amounting to ₹1.80 per equity share of ₹10 face value, for the financial year April 1, 2025, to March 31, 2026. The dividend payment is contingent upon approval by the members at the AGM.